Super-enhancers: critical roles and therapeutic targets in hematologic malignancies
Super-enhancers: critical roles and therapeutic targets in hematologic malignancies is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Super-enhancers: critical roles and therapeutic targets in hematologic malignancies have?
Super-enhancers: critical roles and therapeutic targets in hematologic malignancies has 112 citations in the OpenAlex counts ScholarIQ stores.
When was Super-enhancers: critical roles and therapeutic targets in hematologic malignancies published?
Super-enhancers: critical roles and therapeutic targets in hematologic malignancies has 2019 year in the ScholarIQ index.
What is the open-access status of Super-enhancers: critical roles and therapeutic targets in hematologic malignancies?
Super-enhancers: critical roles and therapeutic targets in hematologic malignancies has gold oa status in the ScholarIQ index.
What is the DOI of Super-enhancers: critical roles and therapeutic targets in hematologic malignancies?
The DOI for Super-enhancers: critical roles and therapeutic targets in hematologic malignancies is on the source record.
What is the PMID of Super-enhancers: critical roles and therapeutic targets in hematologic malignancies?
The PMID for Super-enhancers: critical roles and therapeutic targets in hematologic malignancies is on the source record.
What is the OpenAlex record for Super-enhancers: critical roles and therapeutic targets in hematologic malignancies?
The OpenAlex for Super-enhancers: critical roles and therapeutic targets in hematologic malignancies is on the source record.